Full Definition
GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) are a class of medications approved for type 2 diabetes and obesity. Their rapid adoption has made them the fastest-growing driver of pharmacy spend for employer health plans, with annual costs often exceeding $15,000 per patient.